Full Press Release Details
SAN DIEGO, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to participate in three upcoming investor conferences.
A virtual fireside chat at the TD Cowen Fall Oncology Innovation Summit: Insights for SITC and ASH event at 12:00 p.m. ET / 9:00 a.m. PT on November 3, 2023;
A fireside chat at the Stifel 2023 Healthcare Conference in New York at 11:30 a.m. ET / 8:30 a.m. PT on November 14, 2023; and
A fireside chat at the Jefferies London Healthcare Conference in London at 9:30 a.m. GMT / 5:30 a.m. ET / 2:30 a.m. PT on November 16, 2023.
Live audio webcasts will be available in the Investors section of Kura’s website at www.kuraoncology.com, with archived replays available following all three events.
Executive Vice President, Investor Relations &
Corporate Communications
Alexandra Weingarten
Senior Manager, Corporate Communications
Tags
acute myeloid leukemia
farnesyl transferase inhibitor